Context Therapeutics (CNTX) Q4 2024 Earnings

6NovConfirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.44
-0.29
-0.15
0

Details

Expected EPS
-0.09
Actual EPS
-0.22
Surprise EPS
-0.13
Surprise Percent
+144.44%

Description

Context Therapeutics (CNTX) has reported earnings of -0.22 per share for Q4 2024.

0 Comments

Share your thoughts